Maritza Rubio-Stipec, Sc.D.
Name, Degree: Maritza Rubio-Stipec, Sc.D.
Role(s) in Task Force and Work Group: Director of Methods and Statistics
Institutional Affiliation(s): APIRE
City, State: Arlington, VA
Biographical Sketch:
Dr. Rubio-Stipec currently works as a senior scientist consultant at the American Psychiatric Institute for Research and Education. She holds a master’s degree in economics from New York University and a Doctor in Science degree in epidemiology and biostatistics from Harvard University. She has combined both fields in her career as a professor at the University of Puerto Rico with joint appointments in the departments of economics (in the College of Social Science) and psychiatry of the School of Medicine. At the Behavioral Science Research Institute of the University of Puerto Rico she has acted as co-principal investigator in several NIMH–funded research projects in psychiatric epidemiology. For more than ten years she was a member of the editorial committee of the World Mental Health Composite International Diagnostic Interview (WHO-CIDI) and participated in the development and field testing of the WHO-CIDI 2.1. She directed the first Reference and Training Center for the CIDI in Spanish, where she was in charge of the translation of the CIDI and its computerized version (CIDI-Auto) into Spanish. She has trained many researchers and physicians in the use of these instruments in many parts of the world.
She has many publications, mainly in the area of psychiatric epidemiology, most of them addressing measurement issues, psychometric properties of diagnostic instruments, cross-cultural comparison, risk factors associated with mental illness, the effect of migration, and use of services. In her new role as director of methods and statistics for the DSM-V Taskforce she has been developing a directory of available data sets. This effort will contribute to APA commitment to an “evidence-based” diagnostic system.
Uncompensated affiliations with non-profit or advocacy organizations that may have a direct or indirect interest in psychiatric diagnosis, treatment, or the DSM-V : Three calendar years before nomination and Each year thereafter through the present calendar year. (For 2008, activities to date and commitments for remainder of year.)
|
Non-Profit and Advocacy Organizations |
Year(s) |
Role |
|
None |
|
|
The two tables below represent Dr. Rubio-Stipec’s disclosure of significant interests and affiliations for: (1) The time period including the 3 years prior to nomination to serve on the DSM-V Task Force; the calendar year in which nomination to the Task Force occurred; through the calendar year in which the nomination was approved; and (2) the time period including the calendar year after approval, and each successive year to the present.
Dr. Rubio-Stipec’s has agreed that, from the time of approval through the publication of DSM-V, projected in 2012, her aggregate annual income derived from industry sources (excluding unrestricted research grants) will not exceed $10,000 in any calendar year.
|
KEY NUMBER:
1. Consultation Fees (include scientific advisory boards)
2. Full- or Part-time Employee
3. Industry-related Grant-Research Support received or pending
4. Honoraria (includes Speakers’ Bureau)
5. Stock or other financial options |
6. Expert testimony
7. Royalties (including right to share of revenue or profit from pharmaceutical, device or other development or product)
8. Patents received or pending
9. Officer, director/trustee, executive (specify)
10. Other (specify) |
Disclosure of significant interests including: Three (3) calendar years before nomination, the calendar year of nomination, through the calendar year of approval to serve on the DSM-V Task Force
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
APIRE |
2000-present |
1 |
|
APA |
2000-present |
1 |
|
American Psychiatric Foundation (funded by a consortium of industry entities) |
2004-2007 |
3 (Foundation) |
Disclosure of significant interests Beginning with the calendar year after APA Board of Trustees approval to serve on the DSM-V Task Force, to the present. (For 2008, activities to date and commitments for remainder of year.)
|
Commercial or Other Organization |
Year(s) |
Key #(s) |
|
None |
|
|